Tianjin Pharmaceutical announced that its subsidiary Hubei Jinyao obtained the “Drug Registration Certificate” for bupivacaine hydrochloride injections approved and issued by the State Drug Administration. The specification is 10ml: 75mg, and the drug approval number is Sinopharm standard H20265897. It is declared according to the 3 types of chemicals. After approval, it is treated as if it has passed the consistent evaluation of the quality and efficacy of generic drugs. Up to now, the project has invested about 2.4 million yuan in R&D.

Tianjin Pharmaceutical announced that its subsidiary Hubei Jinyao obtained the “Drug Registration Certificate” for bupivacaine hydrochloride injections approved and issued by the State Drug Administration. The specification is 10ml: 75mg, and the drug approval number is Sinopharm standard H20265897. It is declared according to the 3 types of chemicals. After approval, it is treated as if it has passed the consistent evaluation of the quality and efficacy of generic drugs. Up to now, the project has invested about 2.4 million yuan in R&D.